Global Oligonucleotide Synthesis Market 2021

January 2022 | 17 pages | ID: GC9047641116EN
StrategyHelix Inc

Abstracts

According to a report by StrategyHelix, the global oligonucleotide synthesis market is set to increase by US$ 3,955 million during 2021-2027, growing at a CAGR of 9.8% during the forecast period. Increase in R&D spending from pharmaceutical & biotechnology companies, rise in public & private spending on genomics, the use of synthesized oligonucleotides in molecular diagnostics and clinical applications are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for oligonucleotide synthesis. The global oligonucleotide synthesis market is segmented on the basis of product, application, end user, and region. On the basis of product, the global oligonucleotide synthesis market has been segmented into oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, services. The oligonucleotide drugs segment held the largest revenue share in 2020. By application, the global oligonucleotide synthesis market has been segmented into diagnostics, therapeutics, research. Among these, the research segment was accounted for the highest revenue generator in 2020. Based on end user, the global oligonucleotide synthesis market is categorized into pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes. The academic research institutes segment captured the largest share of the market in 2020. Geographically, the global oligonucleotide synthesis market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global oligonucleotide synthesis market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Biolegio BV, Biolytic Lab Performance Inc., Danaher Corporation, Eurofins Scientific SE, LGC Ltd., Merck KGaA, Microsynth AG, Thermo Fisher Scientific Inc.

Report Scope
Product: oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, services
Application: diagnostics, therapeutics, research
End user: pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global oligonucleotide synthesis market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY PRODUCT

Oligonucleotide drugs
Synthesized oligonucleotides
Reagents
Equipment
Services

PART 4. MARKET BREAKDOWN BY APPLICATION

Diagnostics
Therapeutics
Research

PART 5. MARKET BREAKDOWN BY END USER

Pharmaceutical & biotechnology companies
Diagnostic laboratories
Academic research institutes

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

Agilent Technologies, Inc.
Biolegio BV
Biolytic Lab Performance, Inc.
Danaher Corporation
Eurofins Scientific SE
LGC Ltd.
Merck KGaA
Microsynth AG
Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer